Crystal L. Mackall

Parker Institute for Cancer Immunotherapy

Also affiliated with Stanford University

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile

0.361Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

A Phase I, Open-Label, Dose Escalation Study of Enoblituzumab in Children and Young Adults with B7-H3–Expressing Relapsed or Refractory Solid Tumors

Cancer Research Communications(2025)10.1158/2767-9764.crc-25-0293

Top 49%

0.361DataRank

Top 49%7 citations

Kimberly A. McDowell, Paul M. Sondel, Paul R. Hutson, Rosandra N. Kaplan, Julie R. Park +4 more

Papers

Driven by 48 papers — median percentile 51. Top paper: “Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL”.

Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL

Journal of Clinical Oncology(2021)10.1200/jco.20.02262

N/A

6.9DataRank · unranked

362 citations

Daniel W. Lee, Bonnie Yates, Constance M. Yuan, Haneen Shalabi, Staci Martin +9 more

Nivolumab in children and young adults with relapsed or refractory solid tumours or lymphoma (ADVL1412): a multicentre, open-label, single-arm, phase 1–2 trial

The Lancet Oncology(2020)10.1016/s1470-2045(20)30023-1

N/A

5.0DataRank · unranked

337 citations

Elizabeth Fox, Melinda S. Merchant, Joel M. Reid, Rachel A. Kudgus, Xiaowei Liu +6 more

Impact of cytokine release syndrome on cardiac function following CD19 CAR-T cell therapy in children and young adults with hematological malignancies

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-001159

N/A

4.3DataRank · unranked

102 citations

Vandana Sachdev, Amita Kulshreshtha, Julia W. Cohen, Bonnie Yates, Doug R Rosing +7 more

CD19/22 CAR T cells in children and young adults with B-ALL: phase 1 results and development of a novel bicistronic CAR

Blood(2022)10.1182/blood.2022015795

N/A

3.6DataRank · unranked

177 citations

Haiying Qin, Angela Su, Bonnie Yates, Pamela L. Wolters, Seth M. Steinberg +30 more

Dynamic chromatin regulatory landscape of human CAR T cell exhaustion

Proceedings of the National Academy of Sciences(2021)10.1073/pnas.2104758118

N/A

1.9DataRank · unranked

67 citations

Rachel C. Lynn, Jeff M. Granja, Evan Weber, Maxwell R. Mumbach, Yang Zhao +8 more

Neurotoxicity following CD19/CD28ζ CAR T-cells in children and young adults with B-cell malignancies

Neuro-Oncology(2022)10.1093/neuonc/noac034

N/A

0.985DataRank · unranked

32 citations

Staci Martin, Bonnie Yates, Pamela L. Wolters, Claire M. Kaplan, Hannah Smith +10 more

Tuning the Antigen Density Requirement for CAR T-cell Activity

Cancer Discovery(2020)10.1158/2159-8290.cd-19-0945

N/A

0.958DataRank · unranked

591 citations

Skyler P. Rietberg, Elena Sotillo, Rui Dong, Vipul T. Vachharajani, Louai Labanieh +15 more

Factors Impacting Overall and Event-Free Survival following Post-Chimeric Antigen Receptor T Cell Consolidative Hematopoietic Stem Cell Transplantation

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.10.011

N/A

0.770DataRank · unranked

19 citations

Seth M. Steinberg, Bonnie Yates, Daniel W. Lee, Lauren Little, Crystal L. Mackall +3 more

NOT-Gated CD93 CAR T Cells Effectively Target AML with Minimized Endothelial Cross-Reactivity

Blood Cancer Discovery(2021)10.1158/2643-3230.bcd-20-0208

N/A

0.681DataRank · unranked

93 citations

Feifei Zhao, Katherine A. Freitas, Kevin R. Parker, Peng Xu, Amy C. Fan +12 more

Incidence and risk factors associated with bleeding and thrombosis following chimeric antigen receptor T-cell therapy

Blood Advances(2021)10.1182/bloodadvances.2021004716

N/A

0.659DataRank · unranked

80 citations

Juliana Craig, John H. Baird, Jay Y. Spiegel, Lori Muffly, James L. Zehnder +16 more

HLH-like toxicities predict poor survival after the use of tisagenlecleucel in children and young adults with B-ALL

Blood Advances(2023)10.1182/bloodadvances.2022008893

N/A

0.515DataRank · unranked

30 citations

Stephanie J. Si Lim, Kyle Ishikawa, Alexandra Dreyzin, Anant Vatsayan, John J. Chen +28 more

Transient “rest” induces functional reinvigoration and epigenetic remodeling in exhausted CAR-T cells

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.01.26.920496

N/A

0.442DataRank · unranked

18 citations

Rachel C. Lynn, Kevin R. Parker, Hima Anbunathan, John Lattin, Elena Sotillo +13 more

A Phase I, Open-Label, Dose Escalation Study of Enoblituzumab in Children and Young Adults with B7-H3–Expressing Relapsed or Refractory Solid Tumors

Cancer Research Communications(2025)10.1158/2767-9764.crc-25-0293

Top 49%

0.361DataRank

Top 49%7 citations

Kimberly A. McDowell, Paul M. Sondel, Paul R. Hutson, Rosandra N. Kaplan, Julie R. Park +4 more

Outcomes After Nonresponse and Relapse Post-Tisagenlecleucel in Children, Adolescents, and Young Adults With B-Cell Acute Lymphoblastic Leukemia

Journal of Clinical Oncology(2022)10.1200/jco.22.01076

N/A

0DataRank · unranked

73 citations

Anne Eaton, Christina Baggott, Jenna Rossoff, Snehit Prabhu, Amy K. Keating +26 more

A Phase I/II Trial of Nivolumab plus Ipilimumab in Children and Young Adults with Relapsed/Refractory Solid Tumors: A Children's Oncology Group Study ADVL1412

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-2164

N/A

0DataRank · unranked

72 citations

Elizabeth Fox, Emasenyie Isikwei, Joel M. Reid, Xiaowei Liu, Charles G. Minard +5 more

Efficacy of second CAR-T (CART2) infusion limited by poor CART expansion and antigen modulation

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2021-004483

N/A

0DataRank · unranked

59 citations

John C. Molina, Kniya DéDé, Daniel Moyer, Ting Zhou, Constance M. Yuan +13 more

The impact of race, ethnicity, and obesity on CAR T-cell therapy outcomes

Blood Advances(2022)10.1182/bloodadvances.2022007676

N/A

0DataRank · unranked

48 citations

John A. Ligon, Paul Borgman, Seth M. Steinberg, Toni Foley, Lauren Little +10 more

397 Deep myeloid cell profiling provides new insights into modulators of CAR T cell expansion in patients with solid tumor malignancies

Regular and Young Investigator Award Abstracts(2022)10.1136/jitc-2022-sitc2022.0397

N/A

0DataRank · unranked

2 citations

Sneha Ramakrishna, Tara Murty, Cristina Contreras, Ahmad Alimadadi, Norma C. Gutiérrez +17 more

Enhanced Effector Activity of Mediator Kinase Module Deficient CAR-T Cells

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.09.02.506235

N/A

0DataRank · unranked

0 citations

Julia A. Belk, Elena Sotillo, Bence Dániel, Katalin Sandor, Dorota D. Klysz +12 more

362 Defining T cell exhaustion and memory correlates of GD2 CAR T cell expansion in pediatric patients with solid tumor malignancies

Regular and Young Investigator Award Abstracts(2022)10.1136/jitc-2022-sitc2022.0362

N/A

0DataRank · unranked

0 citations

Sneha Ramakrishna, Sabina Kaczanowska, Cristina Contreras, Caroline Duault, Priyanka Balasubrahmanyam +14 more

Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcoma

Cell Reports Medicine(2023)10.1016/j.xcrm.2023.101212

N/A

0DataRank · unranked

26 citations

Jun S. Wei, Nityashree Shivaprasad, Steven L. Highfill, Berkley E. Gryder, David Milewski +24 more

Tisagenlecleucel utilisation and outcomes across refractory, first relapse and multiply relapsed B-cell acute lymphoblastic leukemia: a retrospective analysis of real-world patterns

EClinicalMedicine(2023)10.1016/j.eclinm.2023.102268

N/A

0DataRank · unranked

11 citations

Yimei Li, Snehit Prabhu, Christina Baggott, Khanh Nguyen, Holly Pacenta +23 more

Directed Evolution of Genetically Encoded LYTACs for Cell-Mediated Delivery

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.11.14.567117

N/A

0DataRank · unranked

5 citations

Sean A. Yamada‐Hunter, Louai Labanieh, Elena Sotillo, Joleen S. Cheah, David S. Roberts +4 more

Data from Killing of Resistant Cancer Cells with Low Bak by a Combination of an Antimesothelin Immunotoxin and a TRAIL Receptor 2 Agonist Antibody

(2023)10.1158/1078-0432.c.6519497

N/A

0DataRank · unranked

0 citations

Laiman Xiang, Crystal L. Mackall, Ira Pastan, Xing Du

Data from A Pilot Study of Consolidative Immunotherapy in Patients with High-Risk Pediatric Sarcomas

(2023)10.1158/1078-0432.c.6516826.v1

N/A

0DataRank · unranked

0 citations

Eunice H. Rhee, Elizabeth J. Read, Hanh Khuu, Susan F. Leitman, Donna Bernstein +9 more

Data from A Phase I/II Trial of Nivolumab plus Ipilimumab in Children and Young Adults with Relapsed/Refractory Solid Tumors: A Children's Oncology Group Study ADVL1412

(2023)10.1158/1078-0432.c.6532749

N/A

0DataRank · unranked

0 citations

Elizabeth Fox, Emasenyie Isikwei, Joel M. Reid, Xiaowei Liu, Charles G. Minard +5 more

Data from A Phase I/II Trial of Nivolumab plus Ipilimumab in Children and Young Adults with Relapsed/Refractory Solid Tumors: A Children's Oncology Group Study ADVL1412

(2023)10.1158/1078-0432.c.6532749.v1

N/A

0DataRank · unranked

0 citations

Elizabeth Fox, Emasenyie Isikwei, Joel M. Reid, Xiaowei Liu, Charles G. Minard +5 more

Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy

New England Journal of Medicine(2024)10.1056/nejmoa2401361

N/A

0DataRank · unranked

190 citations

Takeshi Sugio, Troy Noordenbos, Shuyu Shi, Philip L. Bulterys, Chih Long Liu +12 more

A versatile CRISPR-Cas13d platform for multiplexed transcriptomic regulation and metabolic engineering in primary human T cells

Cell(2024)10.1016/j.cell.2024.01.035

N/A

0DataRank · unranked

115 citations

Elena Sotillo, Jeremy Bjelajac, Xingyu Chen, Meena Malipatlolla, Justin A. Guerrero +7 more

The cytokine Meteorin-like inhibits anti-tumor CD8+ T cell responses by disrupting mitochondrial function

Immunity(2024)10.1016/j.immuni.2024.07.003

N/A

0DataRank · unranked

44 citations

Ayush Pant, Wikum Dinalankara, John Choi, Aanchal Jain, Ryan T. Nitta +26 more

CAR19 monitoring by peripheral blood immunophenotyping reveals histology-specific expansion and toxicity

Blood Advances(2024)10.1182/bloodadvances.2024012637

N/A

0DataRank · unranked

24 citations

Erin Craig, Cesar Gentille Sanchez, Alain Mina, John Tamaresis, Nadia Kirmani +27 more

Bendamustine is a safe and effective lymphodepletion agent for axicabtagene ciloleucel in patients with refractory or relapsed large B-cell lymphoma

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2024-008975

N/A

0DataRank · unranked

16 citations

Eric Lau, Mark Hamilton, Anmol Goyal, Hrishi Srinagesh, Alexandria Jensen +26 more

An engineered NKp46 antibody for construction of multi-specific NK cell engagers

Protein Engineering Design and Selection(2024)10.1093/protein/gzae013

N/A

0DataRank · unranked

6 citations

Sainiteesh Maddineni, Madeleine Landry, Celeste Diaz, Aanya Tashfeen, Sean A. Yamada‐Hunter +5 more

INSPIRED Symposium Part 5: Expanding the Use of CAR T Cells in Children and Young Adults

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.04.004

N/A

0DataRank · unranked

1 citations

Vanessa A. Fabrizio, Richard Aplenc, Stephan A. Grupp, Crystal L. Mackall, Robbie G. Majzner +5 more

Novel NanoLuc substrates enable bright two-population bioluminescence imaging in animals

Nature Methods(2020)10.1038/s41592-020-0889-6

N/A

0DataRank · unranked

208 citations

Joel R. Walker, Yun‐Hee Park, Thomas P. Smith, Lan Xiang Liu, Mary P. Hall +14 more

Characterization and prediction of prolonged severe neutropenia in pediatric patients receiving tisagenlecleucel

Blood Advances(2025)10.1182/bloodadvances.2025016824

N/A

0DataRank · unranked

2 citations

Subodh Selukar, Aimee C. Talleur, Samira Deshpande, Gabriela Llaurador Caraballo, Vanessa A. Fabrizio +34 more

The Emerging Landscape of Immune Cell Therapies

Cell(2020)10.1016/j.cell.2020.03.001

N/A

0DataRank · unranked

458 citations

Marcela V. Maus, Crystal L. Mackall, Evan W. Weber

Disease detection methodologies in relapsed B‐cell acute lymphoblastic leukemia: Opportunities for improvement

Pediatric Blood & Cancer(2020)10.1002/pbc.28149

N/A

0DataRank · unranked

14 citations

Constance M. Yuan, Amita Kulshreshtha, Alina Dulau‐Florea, Dalia Salem, Gaurav K. Gupta +12 more

Transient rest restores functionality in exhausted CAR-T cells through epigenetic remodeling

Science(2021)10.1126/science.aba1786

N/A

0DataRank · unranked

607 citations

Kevin R. Parker, Elena Sotillo, Rachel C. Lynn, Hima Anbunathan, John Lattin +21 more

Immune reconstitution and infectious complications following axicabtagene ciloleucel therapy for large B-cell lymphoma

Blood Advances(2021)10.1182/bloodadvances.2020002732

N/A

0DataRank · unranked

194 citations

David J. Epstein, John Tamaresis, Zachary Ehlinger, Jay Y. Spiegel, Juliana Craig +18 more

GPC2-CAR T cells tuned for low antigen density mediate potent activity against neuroblastoma without toxicity

Cancer Cell(2021)10.1016/j.ccell.2021.12.005

N/A

0DataRank · unranked

164 citations

Kristopher R. Bosse, Zhongyu Zhu, Doncho V. Zhelev, Robbie G. Majzner, Molly Radosevich +36 more

Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy

Blood Advances(2021)10.1182/bloodadvances.2021006418

N/A

0DataRank · unranked

113 citations

Jaap Jan Boelens, Audrey Mauguen, Christina Baggott, Snehit Prabhu, Emily Egeler +27 more

Infectious complications of CAR T-cell therapy across novel antigen targets in the first 30 days

Blood Advances(2021)10.1182/bloodadvances.2021004896

N/A

0DataRank · unranked

73 citations

Bonnie Yates, Seth M. Steinberg, Shilpa Shahani, John C. Molina, Tara N. Palmore +10 more

Allogeneic CAR Invariant Natural Killer T Cells Exert Potent Antitumor Effects through Host CD8 T-Cell Cross-Priming

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-1329

N/A

0DataRank · unranked

56 citations

Juliane K. Lohmeyer, Toshihito Hirai, Kristina Maas‐Bauer, Maite Álvarez, Arielle S. Wenokur +7 more

Delivery of CAR-T Cells in a Transient Injectable Stimulatory Hydrogel Niche Improves Treatment of Solid Tumors

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.12.20.473538

N/A

0DataRank · unranked

9 citations

Louai Labanieh, Dorota D. Klysz, Gillie A. Roth, Peng Xu, Omokolade Adebowale +13 more

Allogeneic CAR-invariant Natural Killer T Cells Exert Potent Antitumor Effects Through Host CD8 T Cell Cross-Priming

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.02.03.428987

N/A

0DataRank · unranked

5 citations

Juliane K. Lohmeyer, Toshihito Hirai, Kristina Maas‐Bauer, Maite Álvarez, Arielle S. Wenokur +7 more

Genome-wide CRISPR screens of T cell exhaustion identify chromatin remodeling factors that limit T cell persistence

Cancer Cell(2022)10.1016/j.ccell.2022.06.001

N/A

0DataRank · unranked

355 citations

Winnie Yao, Nghi Ly, Katherine A. Freitas, Yanting Chen, Quanming Shi +15 more

Enhanced T cell effector activity by targeting the Mediator kinase module

Science(2022)10.1126/science.abn5647

N/A

0DataRank · unranked

147 citations

Julia A. Belk, Elena Sotillo, Patrick J. Quinn, María C. Ramello, Meena Malipatlolla +16 more

Crystal L. Mackall

Indexed papers

Top data-sharing exemplar

Papers